Drug-induced lipodystrophy
Drug-induced lipodystrophy (pronunciation: /ˈdrʌɡ ɪnˈdjuːst lɪpəʊˈdɪstrəfi/) is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. It's a form of lipodystrophy, which is often caused by the use of certain medications.
Etymology
The term "drug-induced lipodystrophy" is derived from the following words: "drug-induced", which refers to conditions caused by the use of drugs, and "lipodystrophy", which comes from the Greek words "lipos" meaning fat, "dys" meaning abnormal or difficult, and "trophe" meaning nourishment.
Causes
Drug-induced lipodystrophy is often caused by certain medications, including insulin, protease inhibitors, and corticosteroids. These medications can cause changes in the body's adipose tissue, leading to the development of lipodystrophy.
Symptoms
Symptoms of drug-induced lipodystrophy can vary, but often include loss of subcutaneous fat, fat accumulation in certain areas of the body, and metabolic complications such as insulin resistance, hyperlipidemia, and diabetes mellitus.
Treatment
Treatment for drug-induced lipodystrophy often involves changing or discontinuing the medication that is causing the condition. Other treatments may include liposuction or other surgical procedures to remove excess fat, and medications to manage metabolic complications.
See also
- Lipodystrophy
- Insulin
- Protease inhibitors
- Corticosteroids
- Insulin resistance
- Hyperlipidemia
- Diabetes mellitus
External links
- Medical encyclopedia article on Drug-induced lipodystrophy
- Wikipedia's article - Drug-induced lipodystrophy
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski